Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 1
1988 1
1991 1
1992 2
1993 2
1994 4
1995 5
1996 1
1997 3
1999 3
2000 2
2002 1
2003 3
2005 1
2006 2
2007 2
2008 4
2009 2
2010 2
2011 2
2012 3
2013 3
2014 2
2015 2
2017 2
2018 1
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia.
Herrmann M, Krupka C, Deiser K, Brauchle B, Marcinek A, Ogrinc Wagner A, Rataj F, Mocikat R, Metzeler KH, Spiekermann K, Kobold S, Fenn NC, Hopfner KP, Subklewe M. Herrmann M, et al. Among authors: mocikat r. Blood. 2018 Dec 6;132(23):2484-2494. doi: 10.1182/blood-2018-05-849802. Epub 2018 Oct 1. Blood. 2018. PMID: 30275109
T-helper-1-cell cytokines drive cancer into senescence.
Braumüller H, Wieder T, Brenner E, Aßmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier F, van den Broek M, Häring HU, Handgretinger R, Quintanilla-Martinez L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Röcken M. Braumüller H, et al. Among authors: mocikat r. Nature. 2013 Feb 21;494(7437):361-5. doi: 10.1038/nature11824. Epub 2013 Feb 3. Nature. 2013. PMID: 23376950 Free article.
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours.
Brenner E, Schörg BF, Ahmetlić F, Wieder T, Hilke FJ, Simon N, Schroeder C, Demidov G, Riedel T, Fehrenbacher B, Schaller M, Forschner A, Eigentler T, Niessner H, Sinnberg T, Böhm KS, Hömberg N, Braumüller H, Dauch D, Zwirner S, Zender L, Sonanini D, Geishauser A, Bauer J, Eichner M, Jarick KJ, Beilhack A, Biskup S, Döcker D, Schadendorf D, Quintanilla-Martinez L, Pichler BJ, Kneilling M, Mocikat R, Röcken M. Brenner E, et al. Among authors: mocikat r. Nat Commun. 2020 Mar 12;11(1):1335. doi: 10.1038/s41467-020-14987-6. Nat Commun. 2020. PMID: 32165639 Free PMC article.
Regulatory T Cells in an Endogenous Mouse Lymphoma Recognize Specific Antigen Peptides and Contribute to Immune Escape.
Ahmetlić F, Riedel T, Hömberg N, Bauer V, Trautwein N, Geishauser A, Sparwasser T, Stevanović S, Röcken M, Mocikat R. Ahmetlić F, et al. Among authors: mocikat r. Cancer Immunol Res. 2019 Apr;7(4):600-608. doi: 10.1158/2326-6066.CIR-18-0419. Epub 2019 Mar 20. Cancer Immunol Res. 2019. PMID: 30894379 Free article.
Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.
Deppisch N, Ruf P, Eißler N, Lindhofer H, Mocikat R. Deppisch N, et al. Among authors: mocikat r. Oncotarget. 2017 Jan 17;8(3):4520-4529. doi: 10.18632/oncotarget.13888. Oncotarget. 2017. PMID: 27966460 Free PMC article.
Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies.
Pötzl J, Roser D, Bankel L, Hömberg N, Geishauser A, Brenner CD, Weigand M, Röcken M, Mocikat R. Pötzl J, et al. Among authors: mocikat r. Int J Cancer. 2017 May 1;140(9):2125-2133. doi: 10.1002/ijc.30646. Epub 2017 Feb 22. Int J Cancer. 2017. PMID: 28195314 Free article.
The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors.
Scheuerpflug A, Ahmetlić F, Bauer V, Riedel T, Röcken M, Mocikat R. Scheuerpflug A, et al. Among authors: mocikat r. Cancer Immunol Immunother. 2020 Nov 3. doi: 10.1007/s00262-020-02767-6. Online ahead of print. Cancer Immunol Immunother. 2020. PMID: 33141285
Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L, Hömberg N, Przewoznik M, Brenner C, Riedel T, Flatley A, Polić B, Busch DH, Röcken M, Mocikat R. Belting L, et al. Among authors: mocikat r. Eur J Immunol. 2015 Sep;45(9):2593-601. doi: 10.1002/eji.201445375. Epub 2015 Jul 7. Eur J Immunol. 2015. PMID: 26151313 Free article.
A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy.
Muenchmeier N, Boecker S, Bankel L, Hinz L, Rieth N, Lapa C, Mendler AN, Noessner E, Mocikat R, Nelson PJ. Muenchmeier N, et al. Among authors: mocikat r. PLoS One. 2013 Aug 30;8(8):e72749. doi: 10.1371/journal.pone.0072749. eCollection 2013. PLoS One. 2013. PMID: 24023642 Free PMC article.
CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Hömberg N, Adam C, Riedel T, Brenner C, Flatley A, Röcken M, Mocikat R. Hömberg N, et al. Among authors: mocikat r. Int J Cancer. 2014 Dec 15;135(12):2825-33. doi: 10.1002/ijc.28932. Epub 2014 May 8. Int J Cancer. 2014. PMID: 24771135 Free article.
61 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback